Skip to main content
Caplight Logo









Aitiologic

Aitiologic

Private
ViennaHealthcare & Life Scienceshttps://aitiologic.com/

Last Round

Seed

Sep 15, 2026

Total Funding Raised

$7.4M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Aitiologic is a precision medicine company that develops tissue-resolved liquid biopsy solutions using its proprietary AI-powered aitios® platform to analyze cell-free DNA for early disease detection.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Data as a Service

AI Layer

Application

Keywords

liquid biopsycell-free DNAcfDNAprecision medicinenon-invasive prenatal testingNIPTmedical AIearly disease detectiononcology diagnosticsmulti-modal dataepigenomicsfragmentomicsAI diagnosticsbiotech startupdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aitiologic Comparables

Compare Aitiologic with similar companies based on industry and business-model similarity.

Aitiologic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EarlyDiagnostics
78%
Adela
73%
Natera, Inc.
69%

Aitiologic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 15, 2026
SeedOct 1, 2024

Key People

Founding team and executive leadership

Stephan Beisken

Co-Founder & CTO

Founding Team

Aitiologic Investors

Notable investors and investment history

Aitiologic investors
InvestorRounds
PUSH VCSeed
Ananda VenturesSeed
Heal CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 15, 2026

    $7.4M round led by Heal Capital and Ananda Ventures.

  • Jan 23, 2025

    Grew 75% QoQ from 4 to 7 employees.

Recent news

Latest coverage and updates

  • receives_financingSep 15, 2026

    Aitiologic GmbH received financing of $7.42M in Seed on Sep 15th '26.

Aitiologic Filings

Explore SEC and related filing metadata, where available.

Aitiologic filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Aitiologic's valuation, stock price, and market status.

Is Aitiologic a public or private company?

Aitiologic is a private company.

What is the current stock price of Aitiologic?

Aitiologic is a private company with no public stock price. Caplight tracks Aitiologic's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Aitiologic worth (valuation)?

Valuation information for Aitiologic is not publicly available.

Can I buy Aitiologic stock?

Aitiologic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Aitiologic's last funding round?

Aitiologic's most recent funding round was Seed on September 15, 2026.

Who are the main investors in Aitiologic?

Key investors in Aitiologic include PUSH VC, Ananda Ventures, Heal Capital.

Will Aitiologic IPO soon?

No public IPO plans have been announced for Aitiologic.

How can I track Aitiologic secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aitiologic's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVienna
Employee Range9
Year Founded2023
Last FundingSep 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?